Companies
Dante Labs
a WGS-focused DTC leader offering 30x whole-genome sequencing at promotional pricing around EUR 169, returning raw data and customized reports to a global clientele under IVDR certification.
- Country
- Italy
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | EUR 8 million government grant from Italian Ministry of Economic Development in 2022 | biobase.whitefordresearch.com |
| Capacity | 600 to 700 whole genomes per week (as of 2020) | biobase.whitefordresearch.com · genomeweb.com |
| Certification | CLIA-certified, CAP-accredited, and ISO 15189 medical laboratory accredited | dantelabs.com |
| Certification | CE-IVD certification for clinical WGS test | biobase.whitefordresearch.com · danteomics.com · genomeweb.com |
| Certification | ISO 9001 (quality management) and ISO 13485 (medical devices) certifications | dantelabs.com |
| Production site | Laboratories in L'Aquila, Italy, and in the United States; additional lab presence in United Arab Emirates | dantelabs.com · genomeweb.com |
| Headcount | 16 to 19 employees (Dante Labs Srl, 2023) medium confidence | companyreports.it |
| Headcount | 188 employees (Dante Labs S.r.l., as of 2021-12-31) | italy.globaldatabase.com |
| Revenue | EUR 22,619,472 (2023) | companyreports.it |
| Revenue | EUR 53 million (2021) | italy.globaldatabase.com |
Independent sources: biobase.whitefordresearch.com · companyreports.it · danteomics.com · genomeweb.com · italy.globaldatabase.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| DTC genetic testing | diagnostics-medtech | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.